By reMind Staff — Oregon lawmakers have set a deadline of Dec. 31, 2022, to establish formal rules on the production and administration of psilocybin — just three days before it begins accepting license applications from service providers. Measure 109, aka the Oregon Psilocybin Services Act, legalized the psychedelic beginning in 2023, allowing individuals age […]
By reMind Staff — Green Bay Packers star Aaron Rodgers credits the “two best seasons” of his NFL career to an ayahuasca experience he had in South America. Appearing on the Aubrey Marcus Podcast Wednesday, the legendary quarterback revealed that his consumption of the psychedelic — a plant-based concoction containing DMT — helped him shift […]
By Brad Dunn — Canadian nonprofit TheraPsil is leading a new patient-based lawsuit against the federal government to expand access to psilocybin and related therapies — a case it believes will open the door to national legalization of psychedelics. Last week, seven patients and one healthcare practitioner filed a charter challenge claiming the country’s stringent […]
By reMind Staff — The Diaspora Psychedelic Society has launched two new programs in Jamaica aimed at easing the anxiety and depression associated with life-threatening illnesses and the dying process: Sacred Transitions End-of-Life Retreats and Psychedelic End-of-Life Doula Training. The Sacred Transitions End-of-Life Retreat offers psilocybin explorations with facilitated discussions on the topics of death […]
By reMind Staff — Investment firm Morgan Stanley has released an upbeat analysis of the emerging marketplace for psychedelic medicines and therapies. The report, written by the firm’s Counterpoint Global team of analysts, says the impact of breakthrough psychedelic drugs could far exceed current expectations: “Beyond mental illness and pain-related diseases, psychedelics have the potential […]